ARTICLE | Clinical News
Filgrastim NK regulatory update
March 11, 2013 7:00 AM UTC
Nippon Kayaku said Japan approved Filgrastim NK, a biosimilar of G-CSF, to treat chemotherapy-induced neutropenia (CIN). The product is partnered with Teva. The partners submitted the regulatory appli...